Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    2(67%)

    Phase Distribution

    Phase 2
    2
    67%
    Not Applicable
    1
    33%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 2Efficacy & side effects
    2(66.7%)
    N/ANon-phased studies
    1(33.3%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    2

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(3)

    Detailed Status

    Recruiting2
    Not yet recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    2
    Success Rate
    N/A
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 22 (66.7%)
    N/A1 (33.3%)

    Trials by Status

    not_yet_recruiting133%
    recruiting267%

    Recent Activity

    2 active trials
    Showing 3 of 3
    not_yet_recruitingphase_2

    Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRI

    NCT07861217
    recruitingphase_2

    Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

    NCT06940427
    recruitingnot_applicable

    Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

    NCT07112066

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT07861217Phase 2

    Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRI

    Not Yet Recruiting
    NCT06940427Phase 2

    Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

    Recruiting
    NCT07112066Not Applicable

    Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

    Recruiting

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3